Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients
- 30 November 2004
- journal article
- clinical trial
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 24 (5) , 491-495
- https://doi.org/10.1016/j.ijantimicag.2004.06.006
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- A Comparison of Two Antimicrobial-Impregnated Central Venous CathetersNew England Journal of Medicine, 1999
- Central venous catheter-related bloodstream infections: an analysis of incidence and risk factors in a cohort of 400 patients.Intensive Care Medicine, 1998
- Central Vein Catheter-Related Thrombosis in Intensive Care PatientsChest, 1998
- Infectious Morbidity Associated with Long-Term Use of Venous Access Devices in Patients with CancerAnnals of Internal Medicine, 1993
- Evaluation of an Implantable Venous Access System in a General Oncology PopulationOncology, 1992
- Reduced adherence of micro‐organisms to human mucosal epithelial cells following treatment with Taurolin, a novel antimicrobial agentJournal of Applied Bacteriology, 1987
- Klinische Erfahrungen mit bakteriell kontaminierten Port-A-Cath-Systemen bei TumorpatientenDeutsche Medizinische Wochenschrift (1946), 1987
- The Transmission of Infections in Hospitals by Staff Carriers, Methods of Prevention and ControlInfection Control, 1985
- Structural investigation of a new organic antiseptic: TaurolidineEuropean Journal of Drug Metabolism and Pharmacokinetics, 1983
- Taurolin, a New Chemotherapeutic AgentJournal of Applied Bacteriology, 1976